Amput, P., Palee, S., Arunsak, B., Pratchayasakul, W., Kerdphoo, S., Jaiwongkam, T., . . . Chattipakorn, N. (2020). PCSK9 inhibitor effectively attenuates cardiometabolic impairment in obese-insulin resistant rats.
Chicago Style CitationAmput, Patchareeya, Siripong Palee, Busarin Arunsak, Wasana Pratchayasakul, Sasiwan Kerdphoo, Thidarat Jaiwongkam, Siriporn C. Chattipakorn, and Nipon Chattipakorn. PCSK9 Inhibitor Effectively Attenuates Cardiometabolic Impairment in Obese-insulin Resistant Rats. 2020.
MLA引文Amput, Patchareeya, et al. PCSK9 Inhibitor Effectively Attenuates Cardiometabolic Impairment in Obese-insulin Resistant Rats. 2020.
警告:這些引文格式不一定是100%准確.